221 related articles for article (PubMed ID: 12015084)
1. [Reversal of multidrug-resistance in human leukemia cell line K562/A02 by a cyclosporin D analogue PSC 833].
Dai H; Luo S; Yin A; Peng A
Zhonghua Xue Ye Xue Za Zhi; 2002 Jan; 23(1):23-6. PubMed ID: 12015084
[TBL] [Abstract][Full Text] [Related]
2. [Effect of cyclosporine A, raloxifene and their combination on the reversion of multidrug resistance of K562/A02 line].
Bao W; Chen BA; Gao F; Ding JH; Xu WL; Sheng HL; Gao C; Sun YY; Chen J; Wang J; Zhao G; Ma Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):895-9. PubMed ID: 17096884
[TBL] [Abstract][Full Text] [Related]
3. [The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
Chang HY; Pan KL; Ma FC; Jiao XY; Zhu HF; Liu JH; Huang Y; Cao YH
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):254-8. PubMed ID: 16875558
[TBL] [Abstract][Full Text] [Related]
4. [Reversal effect of berbamine on multidrug resistance of K562/A02 cells and its mechanism].
Han YQ; Yuan JY; Shi YJ; Zhu Y; Wu SL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):604-8. PubMed ID: 14706144
[TBL] [Abstract][Full Text] [Related]
5. [Biomolecular mechanisms of cyclosporine A, tetrandrine and their combination on the reversion of multidrug resistance in human leukemia cell line].
Chen BA; Guo JJ; Cheng J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Nov; 28(11):1010-3. PubMed ID: 19213345
[TBL] [Abstract][Full Text] [Related]
6. [Effects of cytokines on multidrug-resistance in K562/A02 cells].
Liu L; Liu F; Yang C; Qi Y; Yang L; Qi J; Xu Y
Zhonghua Xue Ye Xue Za Zhi; 1997 Dec; 18(12):646-8. PubMed ID: 15625765
[TBL] [Abstract][Full Text] [Related]
7. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
[TBL] [Abstract][Full Text] [Related]
8. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
[TBL] [Abstract][Full Text] [Related]
9. [Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells].
Xiao XB; Xie ZX; Qin Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):422-5. PubMed ID: 17152486
[TBL] [Abstract][Full Text] [Related]
10. [Reversal of multi-drug resistance in K562/A02 cells by small interference RNA of mdr1 gene].
Peng Z; Xiao ZJ; Wang Y; Liu P; Cai YL; Feng WL; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):5-7. PubMed ID: 14990067
[TBL] [Abstract][Full Text] [Related]
11. [In vitro reversal effect of cyclosporin A in combination with cytokines on multidrug resistant cell line K562/A02].
Pu J; Lou F; Zhou Q
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):224-6. PubMed ID: 11601045
[TBL] [Abstract][Full Text] [Related]
12. [Study of mifepristone on reversing multidrug resistance of leukemic cell line K562/A02].
Kong DX; Chen CY; Xu FY; Jia JH
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):555-9. PubMed ID: 18078134
[TBL] [Abstract][Full Text] [Related]
13. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
den Boer ML; Pieters R; Kazemier KM; Janka-Schaub GE; Henze G; Veerman AJ
Leukemia; 1998 Jun; 12(6):912-20. PubMed ID: 9639420
[TBL] [Abstract][Full Text] [Related]
14. [Effects of some traditional Chinese drugs on Mdr1 gene and its expression product in K562/A02 cells].
Gao N; Zhang Y; Mao JQ; Li GQ; Zhou W; Gao B; Gu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):785-9. PubMed ID: 18718061
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of reversal effects of 5-bromotetrandrine and tetrandrine on P-glycoprotein-dependent Resistance to adriamycin in human lukemia cell line K562/A02].
Wang JQ; Chen BA; Cheng J; Xu WL; Sun XC
Ai Zheng; 2008 May; 27(5):491-5. PubMed ID: 18479598
[TBL] [Abstract][Full Text] [Related]
16. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
Jiang XR; Kelsey SM; Wu YL; Newland AC
Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
[TBL] [Abstract][Full Text] [Related]
17. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
18. [Studies on reversing MDR of K562/A02 by ramification of curcumin hydrolyzed].
Huang Y; Dong G; Hong X; Chai H; Yuan X
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2460-3. PubMed ID: 21141501
[TBL] [Abstract][Full Text] [Related]
19. Reversal effects of droloxifene on multidrug resistance in adriamycin-resistant K562 cell line.
Li J; Xu LZ; Yao JJ; Guo WJ; Xia P; Chen Y
Acta Pharmacol Sin; 2001 Nov; 22(11):1023-7. PubMed ID: 11749795
[TBL] [Abstract][Full Text] [Related]
20. Effect of PSC 833 on the cytotoxicity and pharmacodynamics of mitoxantrone in multidrug-resistant K562 cells.
Fukushima T; Yamashita T; Takemura H; Suto H; Kishi S; Urasaki Y; Ueda T
Leuk Res; 2000 Mar; 24(3):249-54. PubMed ID: 10739007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
